Literature DB >> 2953302

Drugs affecting movement disorders.

G Campanella, M Roy, A Barbeau.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2953302     DOI： 10.1146/annurev.pa.27.040187.000553

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  4 in total

1.  Two-photon optical interrogation of individual dendritic spines with caged dopamine.

Authors:  Roberto Araya; Victoria Andino-Pavlovsky; Rafael Yuste; Roberto Etchenique
Journal:  ACS Chem Neurosci       Date:  2013-05-17       Impact factor: 4.418

Review 2.  Current status of dopamine agonists in Parkinson's disease management.

Authors:  J L Montastruc; O Rascol; J M Senard
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

3.  Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology.

Authors:  Douglas A Meyer; Edmond Richer; Stanley A Benkovic; Kanehiro Hayashi; Janice W Kansy; Carly F Hale; Lily Y Moy; Yong Kim; James P O'Callaghan; Li-Huei Tsai; Paul Greengard; Angus C Nairn; Christopher W Cowan; Diane B Miller; Pietro Antich; James A Bibb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

4.  Cdk5 Modulates Long-Term Synaptic Plasticity and Motor Learning in Dorsolateral Striatum.

Authors:  Adan Hernandez; Chunfeng Tan; Gabriel Mettlach; Karine Pozo; Florian Plattner; James A Bibb
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.